Podcast
Daily Cardiology
Hosted by Daily Cardiology Academy · EN
to enjoy learning and progressing in cardiometabolic practice
18episodes
Episodes
Newest firstAll episodes
Impact of Drug-Coated Devices in Patients With Peripheral Arterial Disease
5d ago00:06:12Tap to summarize📚 ESC 2025 Coverage: Do Drug-Coated Devices Offer More Than Just a High Price Tag in PAD? by Dr. Sadeghipour, Interventional Cardiologist.
Transcribe →
High-Dose Influenza Vaccine to Reduce Hospitalizations
2w ago00:02:16Tap to summarize📚 ESC 2025 Coverage: When the Stakes Are Higher: Exploring Flu Vaccine Potency in Older Populations by Dr. Motaghizadeh, Cardiovascular Specialist.
Transcribe →
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
2w ago00:04:02Tap to summarize📚 ESC 2025 Coverage: When Three Drugs Aren’t Enough: Exploring Baxdrostat in Resistant Hypertension by Dr. Ghanavati, Cardiovascular Specialist.
Transcribe →
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous co
2w ago00:04:18Tap to summarize 📚 ESC 2025 Coverage: One Size Doesn’t Fit All: The TAILORED-CHIP Trial Rethinks Dual Antiplatelet Therapy in Complex PCI, by Dr. Bahadori, Cardiovascular Specialist.
Transcribe →
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
2w ago00:02:58Tap to summarize📚 ESC 2025 Coverage: Post-Ablation Management Revisited: Is It Safe to Discontinue Oral Anticoagulation? by Dr. Mirzaeian, Fellowship of Electrophysiology.
Transcribe →
Computed Tomography Angiography or Standard Care After Left Main PCI?
2w ago00:06:13Tap to summarize 📚 ESC 2025 Coverage: Is Seeing Believing? Evaluating CT-Guided Follow-Up After Left Main Coronary Intervention, by Dr. Sezavar, Interventional Cardiologist.
Transcribe →
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias
3w ago00:06:11Tap to summarize 📚 ESC 2025 Coverage: From Normal to Optimal: Rethinking Potassium Targets in Arrhythmia-Prone Patients, by Dr. Bozorgi, Cardiac Electrophysiologist.
Transcribe →
ESC 2025: β-blockers after myocardial infarction with mildly reduced ejection fraction
Jan 500:04:05Tap to summarize📚 ESC 2025 Coverage: Expanding the Benefit Zone: Can β Blockers Help Post-MI Patients with Mildly Reduced Ejection Fraction? by Dr. Yahyavi, Cardiovascular Researcher.
Transcribe →
ESC 2025: SMuRF-less but inflamed
Jan 400:04:25Tap to summarize📚 ESC 2025 Coverage: The SMuRF-less Illusion: Inflammation Unmasks Hidden Cardiovascular Risk in Healthy Women, by Dr. Hafezi, Cardiovascular Specialist.
Transcribe →
ESC 2025: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Jan 300:06:27Tap to summarize📚 ESC 2025 Coverage: A Classic Revived: Digitoxin Lowers Risk in HFrEF When Added to Modern Therapy, by Dr. Talasaz, Clinical Pharmacist.
Transcribe →